Literature DB >> 2549533

Immunobiology of human infection by Entamoeba histolytica.

J I Ravdin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2549533     DOI： 10.1159/000157148

Source DB:  PubMed          Journal:  Pathol Immunopathol Res        ISSN： 0257-2761


× No keyword cloud information.
  7 in total

1.  Pore-forming peptide of pathogenic Entamoeba histolytica.

Authors:  M Leippe; S Ebel; O L Schoenberger; R D Horstmann; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

2.  Intestinal invasion by Entamoeba histolytica.

Authors:  Shahram Solaymani-Mohammadi; William A Petri
Journal:  Subcell Biochem       Date:  2008

3.  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.

Authors:  M Leippe; J Andrä; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

4.  Recombinant expression and biochemical characterization of an NADPH:flavin oxidoreductase from Entamoeba histolytica.

Authors:  I Bruchhaus; S Richter; E Tannich
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  Down-regulation of murine lymphocyte responsiveness to mitogens after treatment with antigens of Entamoeba histolytica.

Authors:  K Chadee; M Denis; K Keller
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

6.  Transfection and continuous expression of heterologous genes in the protozoan parasite Entamoeba histolytica.

Authors:  L Hamann; R Nickel; E Tannich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

7.  Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica.

Authors:  M Leippe; E Tannich; R Nickel; G van der Goot; F Pattus; R D Horstmann; H J Müller-Eberhard
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.